{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:28:43Z","timestamp":1782174523249,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinik M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Extracranial metastases of intracranial meningiomas are rare. Little is known about the mutational pattern of these tumors and their metastatic seeding. Here, we retrospectively explored the molecular alterations of these metastatic lesions and their respective intracranial tumor manifestations.<\/jats:p><jats:p>Histology and genome sequencing were performed in intracranial meningiomas and their extracranial metastatic lesions operated upon between 2002 and 2021. Next-generation DNA\/RNA sequencing (NGS) and methylome analysis were performed to determine molecular alterations.<\/jats:p><jats:p>We analyzed the tumors of five patients with clinically suspected metastases of a meningioma using methylome analysis and next generation panel sequencing of the primary tumors as well as the metastatic lesions. Metastases were found in the spinal cord and one in the lung. In four of these patients, molecular analyses confirmed metastatic disease, while the fifth patient was found to harbor two molecularly distinct meningiomas. On pathological assessment, the primary lesions ranged from CNS WHO grades 1 to 3 (integrated molecular-morphologic meningioma classification scores 2 to 6). Of the four true metastatic cases, three out of the four metastasizing tumors harbored alterations in the BAP1 gene, comprising a stop-mutation combined with copy-number loss (WHO grade 1), copy number loss (WHO grade 3) and a frameshift mutation (WHO grade 2). Furthermore, the latter was confirmed to harbor a BAP1 tumor predisposition syndrome. The fourth metastasizing tumor had copy-number losses in NF2 and PTEN. Only one of four showed CDKN2A homozygous deletion; none showed TERT promotor mutation.<\/jats:p><jats:p>Our results molecularly confirm true metastatic disease in four meningioma patients. BAP1 gene alterations were the most frequent. Larger cohorts, most likely from multicenter studies are necessary to evaluate the role of BAP-1 alterations to further understand the metastatic spread in meningiomas. for metastatic spread and might indicate patients at risk for metastatic spread. Further explorations within larger cohorts are necessary to validate these findings which might influence the clinical management in the future.<\/jats:p>","DOI":"10.1186\/s40478-023-01505-0","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T11:02:38Z","timestamp":1673694158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mutational signature of extracranial meningioma metastases and their respective primary tumors"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2890-5664","authenticated-orcid":false,"given":"A.","family":"Biczok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Thorsteinsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Karschnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. C.","family":"Ruf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Tonn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Herms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Schichor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"Dorostkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,14]]},"reference":[{"key":"1505_CR1","doi-asserted-by":"publisher","first-page":"e12970","DOI":"10.1111\/bpa.12970","volume":"32","author":"AS Berghoff","year":"2022","unstructured":"Berghoff AS, Hielscher T, Ricken G, Furtner J, Schrimpf D, Widhalm G, Rajky U, Marosi C, Hainfellner JA, von Deimling A et al (2022) Prognostic impact of genetic alterations and methylation classes in meningioma. Brain Pathol 32:e12970. https:\/\/doi.org\/10.1111\/bpa.12970","journal-title":"Brain Pathol"},{"key":"1505_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3171\/2015.6.jns15591","volume":"125","author":"WL Bi","year":"2016","unstructured":"Bi WL, Abedalthagafi M, Horowitz P, Agarwalla PK, Mei Y, Aizer AA, Brewster R, Dunn GP, Al-Mefty O, Alexander BM et al (2016) Genomic landscape of intracranial meningiomas. J Neurosurg 125:525\u2013535. https:\/\/doi.org\/10.3171\/2015.6.jns15591","journal-title":"J Neurosurg"},{"key":"1505_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-017-0014-7","volume-title":"Genomic landscape of high-grade meningiomas","author":"WL Bi","year":"2017","unstructured":"Bi WL, Greenwald NF, Abedalthagafi M, Wala J, Gibson WJ, Agarwalla PK, Horowitz P, Schumacher SE, Esaulova E, Mei Y et al (2017) Genomic landscape of high-grade meningiomas. Doi, NPJ Genom Med. https:\/\/doi.org\/10.1038\/s41525-017-0014-7"},{"key":"1505_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fsurg.2016.00040","volume":"3","author":"WL Bi","year":"2016","unstructured":"Bi WL, Zhang M, Wu WW, Mei Y, Dunn IF (2016) Meningioma genomics: diagnostic, prognostic, and therapeutic applications. Front Surg 3:40. https:\/\/doi.org\/10.3389\/fsurg.2016.00040","journal-title":"Front Surg"},{"key":"1505_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11060-019-03312-x","volume":"145","author":"A Biczok","year":"2019","unstructured":"Biczok A, Jungk C, Egensperger R, von Deimling A, Suchorska B, Tonn JC, Herold-Mende C, Schichor C (2019) Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome. J Neurooncol 145:469\u2013477. https:\/\/doi.org\/10.1007\/s11060-019-03312-x","journal-title":"J Neurooncol"},{"key":"1505_CR6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11060-018-2912-7","volume":"139","author":"A Biczok","year":"2018","unstructured":"Biczok A, Kraus T, Suchorska B, Terpolilli NA, Thorsteinsdottir J, Giese A, Tonn JC, Schichor C (2018) TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas. J Neurooncol 139:671\u2013678. https:\/\/doi.org\/10.1007\/s11060-018-2912-7","journal-title":"J Neurooncol"},{"key":"1505_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/CCO.0000000000000687","volume":"32","author":"C Birzu","year":"2020","unstructured":"Birzu C, Peyre M, Sahm F (2020) Molecular alterations in meningioma: prognostic and therapeutic perspectives. Curr Opin Oncol 32:613\u2013622. https:\/\/doi.org\/10.1097\/CCO.0000000000000687","journal-title":"Curr Opin Oncol"},{"key":"1505_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469\u2013474. https:\/\/doi.org\/10.1038\/nature26000","journal-title":"Nature"},{"key":"1505_CR9","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1158\/2159-8290.CD-19-1220","volume":"10","author":"M Carbone","year":"2020","unstructured":"Carbone M, Harbour JW, Brugarolas J, Bononi A, Pagano I, Dey A, Krausz T, Pass HI, Yang H, Gaudino G (2020) Biological mechanisms and clinical significance of BAP1 mutations in human cancer. Cancer Discov 10:1103\u20131120. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-1220","journal-title":"Cancer Discov"},{"key":"1505_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1227\/01.Neu.0000335070.37943.09","volume":"63","author":"KL Chaichana","year":"2008","unstructured":"Chaichana KL, Jallo GI, McGirt MJ, Goldstein IM, Tobias ME, Kothbauer KF (2008) Extent of surgical resection of malignant astrocytomas of the spinal cord: outcome analysis of 35 patients. Neurosurgery 63:55\u201361. https:\/\/doi.org\/10.1227\/01.Neu.0000335070.37943.09","journal-title":"Neurosurgery"},{"key":"1505_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11060-016-2181-2","volume":"129","author":"C Champeaux","year":"2016","unstructured":"Champeaux C, Wilson E, Shieff C, Khan AA, Thorne L (2016) WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment. J Neurooncol 129:337\u2013345. https:\/\/doi.org\/10.1007\/s11060-016-2181-2","journal-title":"J Neurooncol"},{"key":"1505_CR12","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3171\/2019.1.JNS181771","volume":"132","author":"CL Dalle Ore","year":"2019","unstructured":"Dalle Ore CL, Magill ST, Yen AJ, Shahin MN, Lee DS, Lucas CG, Chen WC, Viner JA, Aghi MK, Theodosopoulos PV et al (2019) Meningioma metastases: incidence and proposed screening paradigm. J Neurosurg 132:1447\u20131455. https:\/\/doi.org\/10.3171\/2019.1.JNS181771","journal-title":"J Neurosurg"},{"key":"1505_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40880-018-0291-2","volume":"38","author":"Y Du","year":"2018","unstructured":"Du Y, Lu T, Huang S, Ren F, Cui G, Chen J (2018) Somatic mutation landscape of a meningioma and its pulmonary metastasis. Cancer Commun (Lond) 38:16. https:\/\/doi.org\/10.1186\/s40880-018-0291-2","journal-title":"Cancer Commun (Lond)"},{"key":"1505_CR14","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1158\/0008-5472.CAN-13-3109","volume":"74","author":"IH Ismail","year":"2014","unstructured":"Ismail IH, Davidson R, Gagne JP, Xu ZZ, Poirier GG, Hendzel MJ (2014) Germline mutations in BAP1 impair its function in DNA double-strand break repair. Cancer Res 74:4282\u20134294. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-3109","journal-title":"Cancer Res"},{"key":"1505_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.wneu.2017.01.070","volume":"101","author":"RA Kessler","year":"2017","unstructured":"Kessler RA, Garzon-Muvdi T, Yang W, Weingart J, Olivi A, Huang J, Brem H, Lim M (2017) Metastatic atypical and anaplastic meningioma: a case series and review of the literature. World Neurosurg 101:47\u201356. https:\/\/doi.org\/10.1016\/j.wneu.2017.01.070","journal-title":"World Neurosurg"},{"key":"1505_CR16","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"key":"1505_CR17","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"1505_CR18","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1200\/JCO.21.00784","volume":"39","author":"SLN Maas","year":"2021","unstructured":"Maas SLN, Stichel D, Hielscher T, Sievers P, Berghoff AS, Schrimpf D, Sill M, Euskirchen P, Blume C, Patel A et al (2021) Integrated molecular-morphologic meningioma classification: a multicenter retrospective analysis, retrospectively and prospectively validated. J Clin Oncol 39:3839\u20133852. https:\/\/doi.org\/10.1200\/JCO.21.00784","journal-title":"J Clin Oncol"},{"key":"1505_CR19","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","volume":"22","author":"QT Ostrom","year":"2020","unstructured":"Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2020) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013\u20132017. Neuro Oncol 22:iv1\u2013iv96. https:\/\/doi.org\/10.1093\/neuonc\/noaa200","journal-title":"Neuro Oncol"},{"key":"1505_CR20","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2018.78.5204","volume":"36","author":"V Panou","year":"2018","unstructured":"Panou V, Gadiraju M, Wolin A, Weipert CM, Skarda E, Husain AN, Patel JD, Rose B, Zhang SR, Weatherly M et al (2018) Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma. J Clin Oncol 36:2863\u20132871. https:\/\/doi.org\/10.1200\/JCO.2018.78.5204","journal-title":"J Clin Oncol"},{"key":"1505_CR21","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","volume":"92","author":"T Popova","year":"2013","unstructured":"Popova T, Hebert L, Jacquemin V, Gad S, Caux-Moncoutier V, Dubois-d\u2019Enghien C, Richaudeau B, Renaudin X, Sellers J, Nicolas A et al (2013) Germline BAP1 mutations predispose to renal cell carcinomas. Am J Hum Genet 92:974\u2013980. https:\/\/doi.org\/10.1016\/j.ajhg.2013.04.012","journal-title":"Am J Hum Genet"},{"key":"1505_CR22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/363515a0","volume":"363","author":"GA Rouleau","year":"1993","unstructured":"Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B et al (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515\u2013521. https:\/\/doi.org\/10.1038\/363515a0","journal-title":"Nature"},{"key":"1505_CR23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0294-180","volume":"6","author":"MH Ruttledge","year":"1994","unstructured":"Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjold M, Collins VP et al (1994) Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 6:180\u2013184. https:\/\/doi.org\/10.1038\/ng0294-180","journal-title":"Nat Genet"},{"key":"1505_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv377","author":"F Sahm","year":"2016","unstructured":"Sahm F, Schrimpf D, Olar A, Koelsche C, Reuss D, Bissel J, Kratz A, Capper D, Schefzyk S, Hielscher T et al (2016) PTERT promoter mutations and risk of recurrence in Meningioma. J National Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djv377","journal-title":"J National Cancer Inst"},{"key":"1505_CR25","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","volume":"18","author":"F Sahm","year":"2017","unstructured":"Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S, Okonechnikov K, Koelsche C, Reuss DE, Capper D et al (2017) DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 18:682\u2013694. https:\/\/doi.org\/10.1016\/S1470-2045(17)30155-9","journal-title":"Lancet Oncol"},{"key":"1505_CR26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/neuonc\/now235","volume":"19","author":"GM Shankar","year":"2017","unstructured":"Shankar GM, Abedalthagafi M, Vaubel RA, Merrill PH, Nayyar N, Gill CM, Brewster R, Bi WL, Agarwalla PK, Thorner AR et al (2017) Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas. Neuro Oncol 19:535\u2013545. https:\/\/doi.org\/10.1093\/neuonc\/now235","journal-title":"Neuro Oncol"},{"key":"1505_CR27","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/neuonc\/nox094","volume":"19","author":"GM Shankar","year":"2017","unstructured":"Shankar GM, Santagata S (2017) BAP1 mutations in high-grade meningioma: implications for patient care. Neuro Oncol 19:1447\u20131456. https:\/\/doi.org\/10.1093\/neuonc\/nox094","journal-title":"Neuro Oncol"},{"key":"1505_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1167\/tvst.8.3.11","volume":"8","author":"G Stalhammar","year":"2019","unstructured":"Stalhammar G, See TRO, Phillips S, Seregard S, Grossniklaus HE (2019) Digital image analysis of BAP-1 accurately predicts uveal melanoma metastasis. Transl Vis Sci Technol 8:11. https:\/\/doi.org\/10.1167\/tvst.8.3.11","journal-title":"Transl Vis Sci Technol"},{"key":"1505_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ophtha.2017.07.018","volume":"125","author":"E Szalai","year":"2018","unstructured":"Szalai E, Wells JR, Ward L, Grossniklaus HE (2018) Uveal melanoma nuclear BRCA1-associated protein-1 immunoreactivity is an indicator of metastasis. Ophthalmology 125:203\u2013209. https:\/\/doi.org\/10.1016\/j.ophtha.2017.07.018","journal-title":"Ophthalmology"},{"key":"1505_CR30","doi-asserted-by":"publisher","first-page":"17070","DOI":"10.18632\/oncotarget.15043","volume":"8","author":"M Tang","year":"2017","unstructured":"Tang M, Wei H, Han L, Deng J, Wang Y, Yang M, Tang Y, Guo G, Zhou L, Tong A (2017) Whole-genome sequencing identifies new genetic alterations in meningiomas. Oncotarget 8:17070\u201317080. https:\/\/doi.org\/10.18632\/oncotarget.15043","journal-title":"Oncotarget"},{"key":"1505_CR31","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S et al (2011) Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 43:1022\u20131025. https:\/\/doi.org\/10.1038\/ng.912","journal-title":"Nat Genet"},{"key":"1505_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/RLU.0000000000002422","volume":"44","author":"M Unterrainer","year":"2019","unstructured":"Unterrainer M, Ilhan H, Vettermann F, Cyran CC, Tonn JC, Niyazi M, Bartenstein P, Albert NL (2019) Whole-body staging of metastatic atypical meningioma using 68Ga-DOTATATE PET\/CT. Clin Nucl Med 44:227\u2013228. https:\/\/doi.org\/10.1097\/RLU.0000000000002422","journal-title":"Clin Nucl Med"},{"key":"1505_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s40478-020-01040-2","volume":"8","author":"EA Williams","year":"2020","unstructured":"Williams EA, Santagata S, Wakimoto H, Shankar GM, Barker FG 2nd, Sharaf R, Reddy A, Spear P, Alexander BM, Ross JS et al (2020) Distinct genomic subclasses of high-grade\/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic. Acta Neuropathol Commun 8:171. https:\/\/doi.org\/10.1186\/s40478-020-01040-2","journal-title":"Acta Neuropathol Commun"},{"key":"1505_CR34","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/nature09515","volume":"467","author":"S Yachida","year":"2010","unstructured":"Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA et al (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467:1114\u20131117. https:\/\/doi.org\/10.1038\/nature09515","journal-title":"Nature"},{"key":"1505_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10014-016-0271-7","volume":"33","author":"S Yuzawa","year":"2016","unstructured":"Yuzawa S, Nishihara H, Tanaka S (2016) Genetic landscape of meningioma. Brain Tumor Pathol 33:237\u2013247. https:\/\/doi.org\/10.1007\/s10014-016-0271-7","journal-title":"Brain Tumor Pathol"},{"key":"1505_CR36","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/neuonc\/now029","volume":"18","author":"G Zadeh","year":"2016","unstructured":"Zadeh G, Karimi S, Aldape KD (2016) PIK3CA mutations in meningioma. Neuro Oncol 18:603\u2013604. https:\/\/doi.org\/10.1093\/neuonc\/now029","journal-title":"Neuro Oncol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01505-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-023-01505-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01505-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T11:03:55Z","timestamp":1673694235000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-023-01505-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,14]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1505"],"URL":"https:\/\/doi.org\/10.1186\/s40478-023-01505-0","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,14]]},"assertion":[{"value":"27 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Tissue sample and data collection were performed in accordance and approval by the local ethics committee. Institutional ethic board approval was obtained (Approval Number: 18\u2013837).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}